Clinical Trial Update: Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) [Phase 2, Phase 3]

View source ↗

Summary

The document reports a Phase 2/Phase 3 clinical trial evaluating emetine for dengue under the EVOLVE Antiviral Initiative. The study status is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• emetine (emetine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Dengue | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING